Skip to content
methotrexate

Structure via PubChem · Public domain (PubChem)

EntityQ422232· pop 42· linked from 1,276 articles

methotrexate

Sign in to save

Also known as amethopterin, 4-amino-10-methylfolic acid, 4-amino-N(10)-methylpteroylglutamic acid, MTX, N-(4-{[(2,4-diamino-6-pteridinyl)methyl]methylamino}benzoyl)-L-glutamic acid

Methotrexate, formerly known as amethopterin, is a chemotherapy agent and immune-system suppressant. It is used to treat cancer, autoimmune diseases, and ectopic pregnancies. Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, gestational trophoblastic disease, and osteosarcoma. Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease. It can be given by mouth or by injection.

OverviewAI-generated

Methotrexate is a chemical compound with the formula C₂₀H₂₂N₈O₅. Its IUPAC name is (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid. The substance has a mass of 454.171 and a weight of 454.4. It possesses a charge of 0, an xlogp of -1.8, and a topological polar surface area of 211. The molecule contains five hydrogen bond donors and twelve hydrogen bond acceptors.

The defined daily dose for methotrexate is 2.5. In scientific literature, the term is associated with 66,595 records. The compound is referenced by 1,276 other encyclopedia articles.

Synthesized by Vinony from 19 facts across 4 sources: Wikidata, PubMed, PubChem, Vinony graph. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.

Key facts

Drug.legal_status
Rx-only
Drug.Watchedfields
changed
Drug.verifiedrevid
464193974
Drug.image
Methotrexate skeletal.svg
Drug.image_class
skin-invert-image
Drug.width
300
Drug.image2
Methotrexate-from-xtal-3D-bs-17.png
Drug.image_class2
bg-transparent
Drug.width2
300
Drug.tradename
Trexall, Rheumatrex, Otrexup, others
Drug.MedlinePlus
a682019
Drug.DailyMedID
Methotrexate
Drug.pregnancy_AU
D
Drug.routes_of_administration
By mouth, intravenous, intramuscular, subcutaneous, intrathecal
Drug.ATC_prefix
L01
Drug.ATC_suffix
BA01
Drug.legal_AU
S4
Drug.legal_CA
Rx-only

via Wikipedia infobox

Chemical data

Formula
C20H22N8O5
Molecular weight
454.4 g/mol
IUPAC name
(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
SMILES
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
InChIKey
FBOZXECLQNJBKD-ZDUSSCGKSA-N
XLogP
-1.8
Polar surface area
211 Ų
H-bond donors
5
H-bond acceptors
12
Formal charge
0

via PubChem

Research

66,595 papers

via PubMed

~15 min read

Encyclopedic overview

13 sections
Contents
  • Medical uses
  • Chemotherapy
  • Autoimmune disorders
  • Atopic dermatitis
  • During pregnancy
  • Administration
  • Adverse effects
  • Drug interactions
  • Vaccine interactions
  • Mechanism of action
  • History
  • References
  • External links

{{Infobox drug | Watchedfields = changed | verifiedrevid = 464193974 | image = Methotrexate skeletal.svg | image_class = skin-invert-image | width = 300 | alt = | image2 = Methotrexate-from-xtal-3D-bs-17.png | image_class2 = bg-transparent | width2 = 300 | alt2 =

| pronounce = | tradename = Trexall, Rheumatrex, Otrexup, others | Drugs.com = | MedlinePlus = a682019 | DailyMedID = Methotrexate | pregnancy_AU = D | routes_of_administration = By mouth, intravenous, intramuscular, subcutaneous, intrathecal | ATC_prefix = L01 | ATC_suffix = BA01 | ATC_supplemental =

Excerpted from Wikipedia’s “methotrexate” article, available under the CC BY-SA 4.0 licence.

Gallery (5)